SALMETEROL XINAFOATE AS MAINTENANCE THERAPY COMPARED WITH ALBUTEROL IN PATIENTS WITH ASTHMA

被引:151
作者
DALONZO, GE
NATHAN, RA
HENOCHOWICZ, S
MORRIS, RJ
RATNER, P
RENNARD, SI
机构
[1] UNIV TEXAS, HLTH SCI CTR, HOUSTON, TX USA
[2] UNIV NEBRASKA, MED CTR, OMAHA, NE USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1994年 / 271卷 / 18期
关键词
D O I
10.1001/jama.271.18.1412
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective.-To compare the efficacy and safety of inhaled salmeterol xinafoate, a long-acting beta(2)-adrenoceptor agonist, with that of albuterol, a short-acting inhaled beta(2)-agonist, in the treatment of asthma. Design.-Randomized, double-blind, placebo-controlled, parallel-group study. Setting.-Eleven outpatient clinical centers. Subjects.-A total of 322 male and female patients at least 12 years of age with chronic symptomatic asthma requiring daily therapy. Intervention.-Patients were treated with salmeterol xinafoate (42 mu g inhaled twice daily), albuterol (180 mu g inhaled four times daily), or placebo (four times a day) for 12 weeks; patients in all three groups could use inhaled albuterol as backup medication for breakthrough symptoms. Main Outcome Measures.-Serial 12-hour forced expiratory flow in 1 second (FEV(1)), peak expiratory flow (PEF), asthma symptoms, nocturnal awakenings due to asthma, episodes of asthma exacerbations, and electrocardiography. Results.-The mean area under the curve for FEV(1) throughout each 12-hour period was consistently greater after a single dose of salmeterol than after two doses of albuterol administered 6 hours apart (P<.001), with the difference ranging from 3.1 to 4.3 L.h. Salmeterol produced an average increase in morning and evening PEF of 26 and 29 L/min, respectively, over pretreatment values compared with decreases of -13 and -3 L/min, respectively, in the albuterol group and -2 L/min both in the morning and evening in the placebo group (P<.001). Patients in the salmeterol group had significantly fewer days and nights with symptoms than did either the albuterol or placebo group (P<.001). Responses to salmeterol were similar at day 1 and at week 12. Adverse events in all treatment groups were equally infrequent, and no clinically significant change in cardiac rhythm was observed with salmeterol treatment. Conclusion.-Salmeterol inhaled twice daily is more effective than albuterol inhaled four times a day (or as needed) in patients with asthma requiring maintenance therapy. No deterioration of asthma control was observed with the use of salmeterol over a 3-month period.
引用
收藏
页码:1412 / 1416
页数:5
相关论文
共 24 条
[1]  
AYRES JG, 1993, AM REV RESPIR DIS, V147, pA61
[2]   SALMETEROL, A NOVEL, LONG-ACTING BETA-2-ADRENOCEPTOR AGONIST - CHARACTERIZATION OF PHARMACOLOGICAL ACTIVITY INVITRO AND INVIVO [J].
BALL, DI ;
BRITTAIN, RT ;
COLEMAN, RA ;
DENYER, LH ;
JACK, D ;
JOHNSON, M ;
LUNTS, LHC ;
NIALS, AT ;
SHELDRICK, KE ;
SKIDMORE, IF .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 104 (03) :665-671
[3]  
BARNES PJ, 1989, NEW ENGL J MED, V321, P1517
[4]  
BRITTON MG, 1992, EUR RESPIR J, V5, P1062
[5]   LONG-TERM EFFECTS OF A LONG-ACTING BETA-2-ADRENOCEPTOR AGONIST, SALMETEROL, ON AIRWAY HYPERRESPONSIVENESS IN PATIENTS WITH MILD ASTHMA [J].
CHEUNG, D ;
TIMMERS, MC ;
ZWINDERMAN, AH ;
BEL, EH ;
DIJKMAN, JH ;
STERK, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (17) :1198-1203
[6]   INHIBITION OF IGE-DEPENDENT HISTAMINE-RELEASE FROM HUMAN DISPERSED LUNG MAST-CELLS BY ANTIALLERGIC DRUGS AND SALBUTAMOL [J].
CHURCH, MK ;
HIROI, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 90 (02) :421-429
[7]  
CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659
[8]   SALMETEROL IN NOCTURNAL ASTHMA - A DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL OF A LONG-ACTING INHALED BETA-2 AGONIST [J].
FITZPATRICK, MF ;
MACKAY, T ;
DRIVER, H ;
DOUGLAS, NJ .
BRITISH MEDICAL JOURNAL, 1990, 301 (6765) :1365-1368
[9]   A WAY OF LOOKING AT AGONISM AND ANTAGONISM - LESSONS FROM SALBUTAMOL, SALMETEROL AND OTHER BETA-ADRENOCEPTOR AGONISTS [J].
JACK, D .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (05) :501-514
[10]   EXACERBATIONS OF ASTHMA IN PATIENTS ON SALMETEROL [J].
JENKINS, MM ;
HILTON, CJ ;
DEKOCK, JC ;
PALMER, JBD .
LANCET, 1991, 337 (8746) :913-914